327 related articles for article (PubMed ID: 28927765)
1. Recurrent vulvovaginal candidiasis.
Blostein F; Levin-Sparenberg E; Wagner J; Foxman B
Ann Epidemiol; 2017 Sep; 27(9):575-582.e3. PubMed ID: 28927765
[TBL] [Abstract][Full Text] [Related]
2. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes.
Yano J; Sobel JD; Nyirjesy P; Sobel R; Williams VL; Yu Q; Noverr MC; Fidel PL
BMC Womens Health; 2019 Mar; 19(1):48. PubMed ID: 30925872
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey.
Foxman B; Muraglia R; Dietz JP; Sobel JD; Wagner J
J Low Genit Tract Dis; 2013 Jul; 17(3):340-5. PubMed ID: 23486072
[TBL] [Abstract][Full Text] [Related]
4. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020.
Benedict K; Singleton AL; Jackson BR; Molinari NAM
BMC Womens Health; 2022 May; 22(1):147. PubMed ID: 35538480
[TBL] [Abstract][Full Text] [Related]
5. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis.
Ge G; Yang Z; Li D; Zhang N; Chen B; Shi D
Front Immunol; 2022; 13():959740. PubMed ID: 35967437
[TBL] [Abstract][Full Text] [Related]
6. Vaginal microbiological flora and sexually transmitted diseases in women with recurrent or current vulvovaginal candidiasis.
Zdolsek B; Hellberg D; Fröman G; Nilsson S; Mårdh PA
Infection; 1995; 23(2):81-4. PubMed ID: 7622268
[TBL] [Abstract][Full Text] [Related]
7. Virulence is one of the mechanisms of vulvovaginal candidiasis recurrence, rather than drug resistance.
Li X; Chen S; Lyu X; Tian J
Med Mycol; 2022 Nov; 60(11):. PubMed ID: 36328948
[TBL] [Abstract][Full Text] [Related]
8. Difference Between the Profiles Presented by Yeasts that Colonize the Vaginal Mucosa or Cause Primary or Recurrent Candidiasis.
Moreira D; Ruiz LS; Leite-Jr DP; Auler ME; Ramos RTB; Costa VT; Lara BR; Gasparetto A; Gandra RF; Melhem MSC; Paula CR
Mycopathologia; 2021 Jun; 186(3):411-421. PubMed ID: 34120275
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women.
Otoo-Annan E; Senoo-Dogbey VE
BMC Public Health; 2024 Jan; 24(1):100. PubMed ID: 38183091
[TBL] [Abstract][Full Text] [Related]
10. Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: 2. Factors that may have influenced the marked changes in sales volumes during the 1990s.
Mårdh PA; Wågström J; Landgren M; Holmén J
Infect Dis Obstet Gynecol; 2004 Jun; 12(2):99-108. PubMed ID: 15739824
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis.
Zhu YX; Li T; Fan SR; Liu XP; Liang YH; Liu P
Health Qual Life Outcomes; 2016 Apr; 14():65. PubMed ID: 27129474
[TBL] [Abstract][Full Text] [Related]
12. Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol.
Lírio J; Giraldo PC; Amaral RL; Sarmento ACA; Costa APF; Gonçalves AK
BMJ Open; 2019 May; 9(5):e027489. PubMed ID: 31122991
[TBL] [Abstract][Full Text] [Related]
13. [Vulvovaginal candidiasis in pregnant women with impaired tolerance for glucose].
Deng QS; Yang HX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):374-6. PubMed ID: 17697596
[TBL] [Abstract][Full Text] [Related]
14. The dynamic changes of vaginal microecosystem in patients with recurrent vulvovaginal candidiasis: a retrospective study of 800 patients.
Yue XA; Chen P; Tang Y; Wu X; Hu Z
Arch Gynecol Obstet; 2015 Dec; 292(6):1285-94. PubMed ID: 26041326
[TBL] [Abstract][Full Text] [Related]
15. [Genital candidiasis].
Ono F; Yasumoto S
Nihon Rinsho; 2009 Jan; 67(1):157-61. PubMed ID: 19177766
[TBL] [Abstract][Full Text] [Related]
16. Beyond fluconazole: A review of vulvovaginal candidiasis diagnosis and treatment.
Hellier SD; Wrynn AF
Nurse Pract; 2023 Sep; 48(9):33-39. PubMed ID: 37643144
[TBL] [Abstract][Full Text] [Related]
17. Analysis of pathogenic factors of Candida albicans and the effect of vaginal immunization on recurrent vulvovaginal candidiasis in mice.
Shao MK; Qi WJ; Hou MY; Luo DD
J Obstet Gynaecol Res; 2022 Mar; 48(3):857-865. PubMed ID: 34970814
[TBL] [Abstract][Full Text] [Related]
18. [Local humoral immunity in vulvovaginal candidiasis].
Amouri I; Hadrich I; Abbes S; Sellami H; Ayadi A
Ann Biol Clin (Paris); 2013; 71(2):151-5. PubMed ID: 23587578
[TBL] [Abstract][Full Text] [Related]
19. Species Distribution and Antifungal Susceptibility Profiles of Isolates from Women with Nonrecurrent and Recurrent Vulvovaginal Candidiasis.
Rolo J; Faria-Gonçalves P; Barata T; Oliveira AS; Gaspar C; Ferreira SS; Palmeira-de-Oliveira R; Martinez-de-Oliveira J; Costa-de-Oliveira S; Palmeira-de-Oliveira A
Microb Drug Resist; 2021 Aug; 27(8):1087-1095. PubMed ID: 33646045
[TBL] [Abstract][Full Text] [Related]
20. Vaginal microbiota of women with frequent vulvovaginal candidiasis.
Zhou X; Westman R; Hickey R; Hansmann MA; Kennedy C; Osborn TW; Forney LJ
Infect Immun; 2009 Sep; 77(9):4130-5. PubMed ID: 19528218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
